Get started
Author

Parsa Lorestani

ORCID: 0009-0008-7217-3097
Observed ORCID: 0009-0008-7217-3097
OpenAlex ID: A5099012769
Targeting gut-microbiota for gastric cancer treatment: a systematic review
2024 · Amir Marashi, Saina Hasany, et al. · Frontiers in Medicine · 37
The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets
2024 · Parsa Lorestani, Mohsen Dashti, et al. · Discover Oncology · 22
PDF
Applications of CRISPR-Cas9 in mitigating cellular senescence and age-related disease progression
2025 · Alireza Azani, Malihe Sharafi, et al. · Clinical and Experimental Medicine · 9
PDF
The safety and efficacy of bispecific T-cell engagers (TCEs) in patients with glioma
2026 · Behrouz Robat-Jazi, Parsa Lorestani, et al. · Clinical and Experimental Medicine · 4
Enhancing T cell infiltration in glioblastoma: a review article on challenges and therapeutic strategies
2025 · Mohammad Amin Habibi, Negar Nejati, et al. · Cancer Treatment and Research Communications · 4
Current Developments of CAR-T and CAR-NK Cell Therapies for Ovarian Cancer
2025 · Alireza Azani, Sahar Hasani, et al. · Stem Cell Reviews and Reports · 3
A Systematic Review and Meta-analysis on the Safety and Efficacy of CAR T Cell Therapy Targeting GPRC5D in Patients with Multiple Myeloma: A New Insight in Cancer Immunotherapy
2025 · Behrouz Robat-Jazi, Mehrdad Mahalleh, et al. · Anti-Cancer Agents in Medicinal Chemistry · 3
The Impact of Cholecystectomy on Colorectal Cancer Risk: A Comprehensive Review on Risk Factors and the Association
2025 · Parsa Lorestani, Ferdos Faghihkhorasani, et al. · Current Gastroenterology Reports · 2
Neoadjuvant stereotactic radiosurgery for brain metastases: A systematic review and meta-analysis
2025 · Bardia Hajikarimloo, Mohammad Amin Habibi, et al. · Neuro-Oncology Practice · 1
The Safety and Efficacy of Anti-LAG-3 for Patients with Melanoma: A Systematic Review and Meta-analysis Study
2025 · Negar Nejati, Behrouz Robat-Jazi, et al. · Anti-Cancer Agents in Medicinal Chemistry · 1
Mechanistic synergies and optimal sequencing of anti‑VEGF plus immune checkpoint inhibition in gastrointestinal cancers
2026 · Parsa Lorestani, Behrouz Robat-Jazi, et al. · Discover Oncology
The Safety and Efficacy of VEGFR Tyrosine Kinase Inhibitors in Patients with Brain Metastasis: A Systematic Review and Meta-analysis
2026 · Behrouz Robat-Jazi, Negar Nejati, et al. · Clinical Cancer Drugs
Exploring the role of non-coding RNAs in retinoblastoma: mechanism of contribution, biomarker potential, therapeutic opportunities, and encountered challenges
2026 · Alireza Azani, Zahra Mehrdad, et al. · Egyptian Journal of Medical Human Genetics
PDF
Clinical Efficacy and Safety of Pembrolizumab Therapy for B-cell Lymphoma: A Systematic Review and Meta-analysis
2025 · Behrouz Robat-Jazi, Mohammad Amin Habibi, et al. · Anti-Cancer Agents in Medicinal Chemistry
Exploring clinical and urinary factors in treatment-resistant vs. treatment-responsive childhood enuresis: a comparative study
2025 · Parsa Lorestani, Alireza Khodadadiyan, et al. · BMC Pediatrics
PDF
Atypical Hemolytic Uremic Syndrome Triggered by COVID ‐19 Infection in a Pediatric Patient With CD46 Mutation
2025 · Parsa Lorestani, Parisa Maleki Dana, et al. · Clinical Case Reports
PDF
Acute aortic dissection after proximal anastomoses of vein grafts: A case report
2025 · Gholamreza Moradi, Alireza Khodadadiyan, et al. · International Journal of Surgery Case Reports
Atypical Hemolytic Uremic Syndrome Triggered by COVID-19 Infection in a Pediatric Patient with CD46 Mutation
2024 · Parisa Maleki Dana, Parsa Lorestani, et al. · Research Square
Works count: 18
Citation count: 85
H-index: 4
I10-index: 2
Year
Topic
Type